SWOG clinical trial number
SWOG-7303

Chemotherapy of Disseminated Testicular Carcinoma with Vinblastine (NSC-49842) and Bleomycin (NSC- 125066) or Actinomycin-D (NSC-3053), Bleomycin and Vincristine (NSC-67574)

Closed
Abbreviated Title
Chemotherapy of Disseminated Testicular Carcinoma with Vinblastine (NSC-49842) and Bleomycin (NSC- 125066) or Actinomycin-D (NSC-3053), Bleomycin and Vincristine (NSC-67574)
Activated
02/21/1973
Closed
06/12/1975

Research committees

Genitourinary Cancer

Publication Information Expand/Collapse

1978

Chemotherapy of disseminated germinal tumors of the testis - comparison of vinblastine and bleomycin with vincristine, bleomycin and actinomycin D.

SC Spigel;RL Stephens;CD Haas;SE Jones;D Lehane;TE Moon;CA Coltman Jr Cancer Treat Rep 62(1):129-130

1974

Combination chemotherapy of testicular carcinoma.

SC Spigel;CA Coltman Jr ASCO

1973

Combination chemotherapy of testicular carcinoma.

SC Spigel;CA Coltman Jr ASCO

Other Clinical Trials

SWOG Clinical Trial Number
S2427

Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy after a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)
Research Committee(s)
Genitourinary Cancer
Activated
09/04/2025
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
CCTG-PR26

A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)
Research Committee(s)
Genitourinary Cancer
Activated
01/30/2025
Open
Phase
SWOG Clinical Trial Number
S2312

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with metastatic castrate-resistant prostate cancer (mCRPC), Stratified by Aggressive Variant Signature
Research Committee(s)
Genitourinary Cancer
Activated
09/03/2024
Accrual
7%
Open
Phase